1.General Anesthesia using Atracurium for Patient with Acute Organophosphate Poisoning: A case report.
Korean Journal of Anesthesiology 2006;51(2):233-235
A 53-year-old man ingested insecticide and stabbed himself in the upper abdomen in an attempt to commit suicide. He presented with nausea, vomiting, excessive salivation and urination as a result of organophosphate poisoning upon admission. He was planned to undergo an exploratory laparotomy under general anesthesia. After placing a neuromuscular monitor, atracurium 10 mg three times before intubation and additional 5 mg bolus were administered when the third twitch appeared during operation. The total dose of atracurium administered was 50 mg, and the total duration of anesthesia was 150 minutes. The patient was not extubated despite the adequate recovery from atracurium in order to protect the sutured liver and there being some concern of the intermediate syndrome. In the intensive care unit, atropine was discontinued 37 hours after poisoning. The patient was extubated successfully 48 hours after poisoning and was kept under close observations on respiration and supportive care. He was discharged 12 days after surgery without any sequela.
Abdomen
;
Anesthesia
;
Anesthesia, General*
;
Atracurium*
;
Atropine
;
Humans
;
Intensive Care Units
;
Intubation
;
Laparotomy
;
Liver
;
Middle Aged
;
Nausea
;
Organophosphate Poisoning*
;
Poisoning
;
Respiration
;
Salivation
;
Suicide
;
Urination
;
Vomiting
2.The Antinociceptive Effect of Intraperitoneally Administered Nonselective Nitric Oxide Synthase Inhibitor on the Rat Formalin Test.
Minhye OH ; Wonhyung LEE ; Youngkwon GO
The Korean Journal of Pain 2006;19(2):142-145
BACKGROUND: Nitric oxide (NO) is involved in the transmission and modulation of nociceptive information at the peripheral, spinal cord and supraspinal levels. We conducted this experiment to assess the antinociceptive effects of a nonselective nitric oxide synthase (NOS) inhibitor, N-nitro-L-arginine methyl ester (L-NAME), on the modulation of pain in rats subjected to the formalin test. METHODS: Formalin 5% was injected in the right hind paw after intraperitoneal (IP) injection of various doses of L-NAME (0.5 mg/kg, 1.5 mg/kg with and without L-arginine 100 mg/kg, 5.0 mg/kg). The number of flinches was measured. RESULTS: Formalin injected into the rat hind paw induced a biphasic nociceptive behavior. IP injected L-NAME diminished the nociceptive behaviors in a dose-dependent manner during phases 1 and 2. The concomitant injection of L-arginine reversed the antinocipetive effect of L-NAME. CONCLUSIONS: The data demonstrates that a nonselective NOS inhibitor, L-NAME, possesses antinociceptive properties in rats subjected to the formalin test, and the antinociceptive effect of L-NAME is reversed by the concomitant administration of L-arginine.
Animals
;
Arginine
;
Formaldehyde*
;
NG-Nitroarginine Methyl Ester
;
Nitric Oxide Synthase*
;
Nitric Oxide*
;
Pain Measurement*
;
Rats*
;
Spinal Cord
3.Higher mitochondrial DNA copy number is associated with lower prevalence of microalbuminuria.
Jung Eun LEE ; Hansoo PARK ; Young Seok JU ; Minhye KWAK ; Jong Il KIM ; Ha Young OH ; Jeong Sun SEO
Experimental & Molecular Medicine 2009;41(4):253-258
It has been suggested that mitochondrial dysfunction contributes to the initiation and development of atherosclerosis and cardiovascular disease. We examined the association between mitochondrial DNA (mtDNA) copy number and microalbuminuria in a cross-sectional community-based study. We measured peripheral blood mtDNA copy number in 694 adults without chronic kidney disease by a real-time PCR method. The overall prevalence of microalbuminuria (defined as an albumin creatinine ratio of 30 to 299 mg/g) was 4.5%. The prevalence of microalbuminuria decreased progressively from the lower to the upper quartiles of mtDNA copy number (6.9%, 5.7%, 2.9%, and 2.3% in quartiles 1, 2, 3, and 4, respectively, P = 0.017 for trend). Multiple logistic regression models showed that the quartile of mtDNA copy number was independently associated with the prevalence of microalbuminuria (P = 0.01 for trend). Compared with the lowest quartile, the highest quartile had an odds ratio of 0.22 for microalbuminuria (95% confidence interval, 0.05 to 0.87; P = 0.03). Higher mtDNA copy number was associated with the lower prevalence of microalbuminuria in a community-based population.
Adult
;
Albuminuria/blood/*epidemiology/*genetics
;
Cross-Sectional Studies
;
DNA, Mitochondrial/blood/*genetics
;
Female
;
*Gene Dosage
;
Humans
;
Male
;
Middle Aged
;
Regression Analysis
;
Young Adult